Portfolio: Vascular Contributions to Cognitive Impairment and Dementia (VCID), for example Vascular Cognitive Impairment (VCI), Vascular Dementia (VaD), Cerebral Amyloid Angiopathy (CAA), and CADASIL
Additional keywords: Small cerebral vessel diseases (e.g. atherosclerosis, arteriolosclerosis); post-stroke VCID; multi-infarct dementia; TBI with vascular lesions that lead to dementia; heart failure related to cognitive decline; cardiovascular and cerebrovascular dysfunction; anti-beta-amyloid immunotherapy
Dr. Xiling Yin joined the National Institute of Neurological Disorders and Stroke (NINDS) as a Program Director in 2024 and is responsible for the NINDS Vascular Contributions to Cognitive Impairment and Dementia (VCID) portfolio. Previously, Dr. Yin was a Health Program Specialist in the NINDS Division of Neuroscience where she supported research portfolios that focused on neurodegenerative disorders including VCID, Alzheimer's Disease (AD), Limbic-predominant Age-related TDP-43 Encephalopathy (LATE), and Multiple Etiology Dementias (MED). Dr. Yin received her master’s degree in public health and M.D. in Clinical Medicine from Peking University and Jining Medical University in China, respectively. She earned her Ph.D. in Molecular Cell Biology and Anatomy from University of Tokyo in Japan, where she investigated the role of kinesin superfamily motor proteins in neurons and neurological disorders focusing on learning and memory deficits, as well as Epilepsy. Her postdoctoral research at Johns Hopkins focused on neuronal cell death and survival, pathological mechanisms underlying neurodegenerative diseases. Prior to joining the NIH, Xiling was a faculty in the Department of Neurology at Johns Hopkins School of Medicine.